Category Archives: Gnosis Lab


Hepatitis B Screening




Many of the difficulties that surveillance systems face in identifying and tracking cases of hepatitis B and hepatitis C are related to the complexity of the infections and their associated progression (see Figures 2-1 and 2-2). This section highlights some of those challenges. Chapter 5 will provide more detail on issues related to screening and identification.

FIGURE 2-1 Natural progression of hepatitis B infection.

FIGURE 2-1 Natural progression of hepatitis B infection.

Abbreviations: HBeAg, hepatitis B e antigen; anti-HBe, antibody to hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.

aTransmission occurs in 90% of infants of HBsAg+/HBeAg+ mothers and 15% of infants of HBsAg+/anti-HBe+ mothers.

b30% of those infected from the age of 1–5 years and under 7% of those infected at the age of 6 years or older.

cAbout 50% of patients by 5 years and 70% of patients by 10 years will seroconvert to anti-HBe.

d15-25% risk of premature death from cirrhosis and HCC.